Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infections.
Publication
, Journal Article
Hart, MK; Palker, TJ; Haynes, BF
Published in: Pharm Biotechnol
1995
Duke Scholars
Published In
Pharm Biotechnol
DOI
ISSN
1078-0467
Publication Date
1995
Volume
6
Start / End Page
821 / 845
Location
United States
Related Subject Headings
- Vaccines, Synthetic
- Peptides
- Molecular Sequence Data
- Humans
- HTLV-I Infections
- HIV-1
- HIV Infections
- Drug Design
- Animals
- Amino Acid Sequence
Citation
APA
Chicago
ICMJE
MLA
NLM
Hart, M. K., Palker, T. J., & Haynes, B. F. (1995). Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infections. Pharm Biotechnol, 6, 821–845. https://doi.org/10.1007/978-1-4615-1823-5_37
Hart, M. K., T. J. Palker, and B. F. Haynes. “Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infections.” Pharm Biotechnol 6 (1995): 821–45. https://doi.org/10.1007/978-1-4615-1823-5_37.
Hart MK, Palker TJ, Haynes BF. Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infections. Pharm Biotechnol. 1995;6:821–45.
Hart, M. K., et al. “Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infections.” Pharm Biotechnol, vol. 6, 1995, pp. 821–45. Pubmed, doi:10.1007/978-1-4615-1823-5_37.
Hart MK, Palker TJ, Haynes BF. Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infections. Pharm Biotechnol. 1995;6:821–845.
Published In
Pharm Biotechnol
DOI
ISSN
1078-0467
Publication Date
1995
Volume
6
Start / End Page
821 / 845
Location
United States
Related Subject Headings
- Vaccines, Synthetic
- Peptides
- Molecular Sequence Data
- Humans
- HTLV-I Infections
- HIV-1
- HIV Infections
- Drug Design
- Animals
- Amino Acid Sequence